Compounders Research Compare

SpyGlass Pharma, Inc. Common Stock(SGP)

Biotechnology · Irvine, CA

$24.94-0.66 (-2.56%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

About SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.

Irvine, CA

76 employees

www.spyglasspharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Patrick H. Mooney

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T17:34:08.144Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:34:08.144Z.

Quote observation: 2026-10-06T17:30:14.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: N/A
Quote price: 24.935

FMP input reference: 77ffd79d43f0055242b38282a97f53e69ef3ec7586b4a3f7de15a7f16befe37a

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

SGP Earnings Yield Metrics

EARNINGS YIELD

N/A

SGP Competitors' Earnings Yield

SpyGlass Pharma, Inc. Common Stock

Current

Market Cap

$833.66M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QuidelOrtho Corporation

Market Cap

$845.91M

Earnings Yield

N/A

TTM Avg

3.42%

3Y Avg

14.26%

5Y Avg

9.75%

SL Science Holding Ltd

Market Cap

$864.30M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Monte Rosa Therapeutics, Inc.

Market Cap

$832.81M

Earnings Yield

N/A

TTM Avg

2.16%

3Y Avg

2.16%

5Y Avg

2.16%

Rigel Pharmaceuticals, Inc.

Market Cap

$859.24M

Earnings Yield

35.14%

TTM Avg

38.06%

3Y Avg

23.44%

5Y Avg

23.44%

Corvus Pharmaceuticals, Inc.

Market Cap

$860.24M

Earnings Yield

N/A

TTM Avg

2.57%

3Y Avg

2.57%

5Y Avg

2.57%

Beta Bionics, Inc.

Market Cap

$830.51M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Alumis Inc.

Market Cap

$830.36M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SI-BONE, Inc.

Market Cap

$860.05M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pacific Biosciences of California, Inc.

Market Cap

$826.23M

Earnings Yield

N/A

TTM Avg

0.29%

3Y Avg

0.29%

5Y Avg

0.29%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
SpyGlass Pharma, Inc. Common Stock (SGP)	$833.66M	N/A	N/A	N/A	N/A
QuidelOrtho Corporation (QDEL)vs ›	$845.91M	N/A	3.42%	14.26%	9.75%
SL Science Holding Ltd (SLBT)vs ›	$864.30M	N/A	N/A	N/A	N/A
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$832.81M	N/A	2.16%	2.16%	2.16%
Rigel Pharmaceuticals, Inc. (RIGL)vs ›	$859.24M	35.14%	38.06%	23.44%	23.44%
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$860.24M	N/A	2.57%	2.57%	2.57%
Beta Bionics, Inc. (BBNX)vs ›	$830.51M	N/A	N/A	N/A	N/A
Alumis Inc. (ALMS)vs ›	$830.36M	N/A	N/A	N/A	N/A
SI-BONE, Inc. (SIBN)vs ›	$860.05M	N/A	N/A	N/A	N/A
Pacific Biosciences of California, Inc. (PACB)vs ›	$826.23M	N/A	0.29%	0.29%	0.29%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics